227 related articles for article (PubMed ID: 36031604)
1. Cellular transcriptional alterations of peripheral blood in Alzheimer's disease.
Song L; Yang YT; Guo Q; ; Zhao XM
BMC Med; 2022 Aug; 20(1):266. PubMed ID: 36031604
[TBL] [Abstract][Full Text] [Related]
2. Integrating peripheral blood and brain transcriptomics to identify immunological features associated with Alzheimer's disease in mild cognitive impairment patients.
Qian XH; Liu XL; Chen SD; Tang HD
Front Immunol; 2022; 13():986346. PubMed ID: 36159817
[TBL] [Abstract][Full Text] [Related]
3. Deciphering cellular transcriptional alterations in Alzheimer's disease brains.
Wang X; Allen M; Li S; Quicksall ZS; Patel TA; Carnwath TP; Reddy JS; Carrasquillo MM; Lincoln SJ; Nguyen TT; Malphrus KG; Dickson DW; Crook JE; Asmann YW; Ertekin-Taner N
Mol Neurodegener; 2020 Jul; 15(1):38. PubMed ID: 32660529
[TBL] [Abstract][Full Text] [Related]
4. Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification.
Zhong H; Zhou X; Uhm H; Jiang Y; Cao H; Chen Y; Mak TTW; Lo RMN; Wong BWY; Cheng EYL; Mok KY; Chan ALT; Kwok TCY; Mok VCT; Ip FCF; Hardy J; Fu AKY; Ip NY
Alzheimers Dement; 2024 Apr; 20(4):2469-2484. PubMed ID: 38323937
[TBL] [Abstract][Full Text] [Related]
5. Increased apoptosis in the platelets of patients with Alzheimer's disease and amnestic mild cognitive impairment.
Zhao S; Zhao J; Zhang T; Guo C
Clin Neurol Neurosurg; 2016 Apr; 143():46-50. PubMed ID: 26895209
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential blood biomarkers for early diagnosis of Alzheimer's disease through RNA sequencing analysis.
Shigemizu D; Mori T; Akiyama S; Higaki S; Watanabe H; Sakurai T; Niida S; Ozaki K
Alzheimers Res Ther; 2020 Jul; 12(1):87. PubMed ID: 32677993
[TBL] [Abstract][Full Text] [Related]
7. Molecular Subtyping of Mild Cognitive Impairment Based on Genetic Polymorphism and Gene Expression.
Li HT; Yuan SX; Wu JS; Zhang XZ; Liu Y; Sun X
J Prev Alzheimers Dis; 2021; 8(2):224-233. PubMed ID: 33569571
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-Mediated Progression of Mild Cognitive Impairment to Dementia.
Cho K
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834242
[TBL] [Abstract][Full Text] [Related]
9. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.
Li B; He Y; Ma J; Huang P; Du J; Cao L; Wang Y; Xiao Q; Tang H; Chen S
Alzheimers Dement; 2019 Oct; 15(10):1357-1366. PubMed ID: 31434623
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial Dysfunction as a Causative Factor in Alzheimer's Disease-Spectrum Disorders: Lymphocytes as a Window to the Brain.
Jörg M; Plehn JE; Friedland K; Müller WE
Curr Alzheimer Res; 2021; 18(10):733-752. PubMed ID: 34879802
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural and Molecular Investigation on Peripheral Leukocytes in Alzheimer's Disease Patients.
Giannelli R; Canale P; Del Carratore R; Falleni A; Bernardeschi M; Forini F; Biagi E; Curzio O; Bongioanni P
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175616
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
De Felice B; Montanino C; Oliva M; Bonavita S; Di Onofrio V; Coppola C
Mol Neurobiol; 2020 Nov; 57(11):4408-4416. PubMed ID: 32737762
[TBL] [Abstract][Full Text] [Related]
13. Identification of Temporal Characteristic Networks of Peripheral Blood Changes in Alzheimer's Disease Based on Weighted Gene Co-expression Network Analysis.
Tang R; Liu H
Front Aging Neurosci; 2019; 11():83. PubMed ID: 31178714
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Peripheral Immune Dysregulation in Alzheimer's Disease and Vascular Dementia.
Guo Z; Peng X; Li HY; Wang Y; Qian Y; Wang Z; Ye D; Ji X; Wang Z; Wang Y; Chen D; Lei H
J Alzheimers Dis; 2019; 71(4):1175-1186. PubMed ID: 31498124
[TBL] [Abstract][Full Text] [Related]
16. Differentially expressed genes in Alzheimer's disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1.
Li QS; De Muynck L
Brain Behav Immun Health; 2021 May; 13():100227. PubMed ID: 34589742
[TBL] [Abstract][Full Text] [Related]
17. Intermittent Hypoxia-Hyperoxia Training Improves Cognitive Function and Decreases Circulating Biomarkers of Alzheimer's Disease in Patients with Mild Cognitive Impairment: A Pilot Study.
Serebrovska ZO; Serebrovska TV; Kholin VA; Tumanovska LV; Shysh AM; Pashevin DA; Goncharov SV; Stroy D; Grib ON; Shatylo VB; Bachinskaya NY; Egorov E; Xi L; Dosenko VE
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671598
[TBL] [Abstract][Full Text] [Related]
18. Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease.
Johnson ECB; Dammer EB; Duong DM; Yin L; Thambisetty M; Troncoso JC; Lah JJ; Levey AI; Seyfried NT
Mol Neurodegener; 2018 Oct; 13(1):52. PubMed ID: 30286791
[TBL] [Abstract][Full Text] [Related]
19. Spatio-temporal convolution for classification of alzheimer disease and mild cognitive impairment.
Turhan G; Küçük H; Isik EO
Comput Methods Programs Biomed; 2022 Jun; 221():106825. PubMed ID: 35636355
[TBL] [Abstract][Full Text] [Related]
20. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.
Leifert WR; Nguyen T; Rembach A; Martins R; Rainey-Smith S; Masters CL; Ames D; Rowe CC; Macaulay SL; François M; Fenech MF;
J Alzheimers Dis; 2015; 48(2):443-52. PubMed ID: 26402008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
